Therapeutic antibodies are widely employed in the surface functionalization of targeted nanosystems that can vehicle chemotherapeutic drugs, gene silencing agents or diagnostic molecules for the diagnosis and treatment of HER-2+ cancer cells [59]. Here, ERBB2 is linked to cancer.